Trials / Completed
CompletedNCT02946931
All-Case Surveillance of Prizbind®
The Drug Use-results Survey (All-Case Surveillance) on Prizbind® for Intravenous Solution 2.5 g in Japan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,402 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate safety and effectiveness of Prizbind® for Intravenous Solution 2.5 g under Japanese clinical condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prizbind® | Prizbind® |
Timeline
- Start date
- 2016-11-18
- Primary completion
- 2020-11-03
- Completion
- 2020-11-03
- First posted
- 2016-10-27
- Last updated
- 2022-09-09
- Results posted
- 2021-12-15
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02946931. Inclusion in this directory is not an endorsement.